Dudediligence.

Twist Bioscience Corporation

TWSTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$84.7MSep ’24$88.7MDec ’24$92.8MMar ’25$96.1MJun ’25$99.0MSep ’25$103.7MDec ’25$110.7MMar ’26$118.4MJun ’26
Net income, by quarter
−$34.7MSep ’24−$31.6MDec ’24−$39.3MMar ’25$20.4MJun ’25−$27.1MSep ’25−$30.5MDec ’25−$44.0MMar ’26−$35.1MJun ’26
Fiscal years, by the month each ended
LineSep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Revenue$132.3M$203.6M$245.1M$313.0M$376.6M
Gross profit$51.7M$84.2M$89.7M$133.3M$191.0M
Operating income−$152.7M−$234.8M−$217.2M−$220.8M−$136.3M
Net income−$152.1M−$217.9M−$204.6M−$208.7M−$77.7M
Operating cash flow−$112.2M−$124.4M−$142.5M−$64.1M−$47.6M
Free cash flow−$139.3M−$226.2M−$170.3M−$69.2M−$75.6M
Cash$465.8M$378.7M$286.5M$226.3M$183.0M
Debt$1.6M$0.00none on filenone on filenone on file
Shares outstanding49.5M56.5M57.6M58.9M60.6M